title: New advances promising in treating neuropathy. Expert explain what's the latest and best.
abstract: Neuropathies among HIV patients have continued to increase in recent years, particularly in the case of antiretroviral toxic neuropathy. Research data suggest that about one-third of HIV patients experience some form of neuropathy symptoms.
mesh_terms: D016263:AIDS-Associated Nephropathy / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D002211:Capsaicin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D009414:Nerve Growth Factors / Q000008:administration & dosage / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects
chemical_list: D000700:Analgesics; D009414:Nerve Growth Factors; D018894:Reverse Transcriptase Inhibitors; C101246:prosaptide; D002211:Capsaicin